Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Nurs 5334 exam 1 ear eye urology bone questions with verified answers., Exams of Nursing

Nurs 5334 exam 1 ear eye urology bone questions with verified answers.

Typology: Exams

2024/2025

Available from 07/06/2025

edvin-brown
edvin-brown 🇺🇸

391 documents

1 / 6

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
Nurs |5334 |exam |1 |ear |eye |urology |bone |
questions |with |verified |answers
Osteoporosis |- |✔✔Progressive |loss |of |bone |mass. |Increased |risk |for |fractures. |Type |1 |occurs |primarily
|in |post |menopausal |women. |Type |2 |is |men |and |women. |Can |be |caused |by |other |diseases |or |
medications. |Such |as |oasis, |steroids, |heparin, |etc.
osteomalacia |- |✔✔Softening |of |the |bone. |Adults |version |of |rickets. |Low |vitamin |D. |Can |also |be |
caused |by |hyperparathryoidism. |Nirmal |vitamin |d |level |is |20-80.
Paget |Disease |- |✔✔Disorder |of |bone |remodeling. |Typically |occurs |in |one |or |more |bones. |They |tend |
to |have |a |high |alkaline |phosphate |level.
Treatment |for |Paget's |Disease |- |✔✔Zoledronic |acid. |Given |once |a |year |via |IV |infusion. |Also |prescribed
|a |high |dose |biphosphonate |and |calcitonin.
Treatment |for |osteomalacia |- |✔✔vitamin |D |and |calcium. |Give |calcitriol |is |vitamin |d |level |is |less |than |
10
Bisphosphonates |- |✔✔-dronate |given |for |treatment |of |osteoporosis, |pagets, |and |osteomalacia
Fosamax |(alendronate) |- |✔✔Classification: |Bone |resorption |inhibitor. |Bisphosphonate
Therapeutic |Effects: |TX |and |prevention |of |post-menopausal |and |cortico-steroid-induced |osteoporosis,
Adverse |Reactions |& |side |effects: |Altered |taste, |photosensitivity, |rash, |musculoskeletal |pain, |fluid |
overload, |esophagitis. |Common |upset |stomach |& |heartburn, |GI |effects
Nursing |Implications |& |teaching:Take |first |thing |in |the |AM, |before |eating |anything; |then |pt |MUST |
remain |upright |for |at |least |30 |mins! |Take |only |with |plain |water. |Monitor |for |GI |side |effects. |Use |
sunscreen |to |prevent |photosensitivity |reactions. |Do |not |give |to |those |with |Renal |insufficiency
pf3
pf4
pf5

Partial preview of the text

Download Nurs 5334 exam 1 ear eye urology bone questions with verified answers. and more Exams Nursing in PDF only on Docsity!

Nurs | 5334 |exam | 1 |ear |eye |urology |bone |

questions |with |verified |answers

Osteoporosis |- |✔✔Progressive |loss |of |bone |mass. |Increased |risk |for |fractures. |Type | 1 |occurs |primarily |in |post |menopausal |women. |Type | 2 |is |men |and |women. |Can |be |caused |by |other |diseases |or | medications. |Such |as |oasis, |steroids, |heparin, |etc. osteomalacia |- |✔✔Softening |of |the |bone. |Adults |version |of |rickets. |Low |vitamin |D. |Can |also |be | caused |by |hyperparathryoidism. |Nirmal |vitamin |d |level |is |20-80. Paget |Disease |- |✔✔Disorder |of |bone |remodeling. |Typically |occurs |in |one |or |more |bones. |They |tend | to |have |a |high |alkaline |phosphate |level. Treatment |for |Paget's |Disease |- |✔✔Zoledronic |acid. |Given |once |a |year |via |IV |infusion. |Also |prescribed |a |high |dose |biphosphonate |and |calcitonin. Treatment |for |osteomalacia |- |✔✔vitamin |D |and |calcium. |Give |calcitriol |is |vitamin |d |level |is |less |than | 10 Bisphosphonates |- |✔✔-dronate |given |for |treatment |of |osteoporosis, |pagets, |and |osteomalacia Fosamax |(alendronate) |- |✔✔Classification: |Bone |resorption |inhibitor. |Bisphosphonate Therapeutic |Effects: |TX |and |prevention |of |post-menopausal |and |cortico-steroid-induced |osteoporosis, Adverse |Reactions |& |side |effects: |Altered |taste, |photosensitivity, |rash, |musculoskeletal |pain, |fluid | overload, |esophagitis. |Common |upset |stomach |& |heartburn, |GI |effects Nursing |Implications |& |teaching:Take |first |thing |in |the |AM, |before |eating |anything; |then |pt |MUST | remain |upright |for |at |least | 30 |mins! |Take |only |with |plain |water. |Monitor |for |GI |side |effects. |Use | sunscreen |to |prevent |photosensitivity |reactions. |Do |not |give |to |those |with |Renal |insufficiency

Raloxifene |(Evista) |- |✔✔Selective |Estrogen |Receptor |Modulator |(SERM) |Osteoporosis. |Give |daily. |For | those |that |are |intolerant |to |bisphosphonates. |Can |cause |hot |flashes. |Don't |give |to |those |with |a | history |of |DVT, |stroke, |MI. |Can |lower |LDL. |Has |estrogen |side |effects. |Do |not |give |if |at |a |high |risk |for | uterine |or |breast |cancer. Duavee |(conjugated |estrogens/bazedoxifene) |- |✔✔First |drug |to |combine |estrogen |with |an |estrogen | agonist/antagonist |(bazedoxifene) Drug |should |be |used |for |the |shortest |duration |possible. |Do |not |give |to |patient |is |they |have |a |uterus | or |previous |DVT, |stroke, |MI, |PE. Calcitonin |(Miacalcin) |- |✔✔nasal |spray |to |decrease |bone |loss |from |osteoporosis; |instruct |pt. |to | alternate |nostrils |each |day |when |administering |the |nasal |spray |to |decrease |rhinitis. |Can |cause |nose | bleeds. |Does |not |affect |osteoporosis |of |the |hip. Teriparatide |(Forteo) |- |✔✔Given |for |osteoporosis. |Only |drug |that |will |build |bone |by |stimulating | osteoblast |(building |of |bone). |Given |subQ |for |up |to |two |years. |No |longer |than |two |years. |After |two | years |give |a |bisphonphosate. Denosumab |(Prolia) |- |✔✔RANKL-inhibitor SQ |every | 6 |months |(Osteoporosis) MOA: -inhibits |osteoclast |formation, |function |and |survival |by |preventing |the |action |of |the |RANKL |receptor -in |turn |increases |bone |mass |and |strength T. |USE: -reserved |for |post-menopausal |women |at |high |risk |of |fracture |or |who |are |intolerant |to |other | treatments ADRs: -back |pain -pain |in |extremities

Detrusor |underactivity |- |✔✔overflow |incontinence. |Trial |with |in |dwelling |catheterization |for |a |few | weeks |to |decompress |the |bladder. |If |not, |response |after |two |weeks, |reinsert |catheter |for |four |weeks. |If |no |response, |can |give |bethanechol urinary |incontinence |- |✔✔inability |to |control |urination; |the |inability |to |retain |urine |in |the |bladder | that |can |lead |to |hygiene |or |social |problems | Affects |at |least | 10 |million |people Associated |with |pressure |ulcers, |skin |irritation |and |falls | Can |lead |to |anxiety, |depression, |embarrassment |and |isolation Testosterone |deficiency |- |✔✔due |to |a |low |level |of |testosterone Can |be |part |of |male |hypogonadism. |Can |lead |to |osteoporosis Alpha |blockers |- |✔✔-osin |(Terazosin, |Doxazosin, |Alfuzosin, |Prazosin, |Tamulosin, |Silodosin)

  • |Drugs |that |block |the |alpha-1 |receptors |found |in |the |smooth |muscle |in |the |bladder, |neck, |and | prostate, |causing |them |to |relax.
  • |ADE: |hypotension, |dizziness, |fatigue, |nasal |stuffiness, |headache, |drowsiness
  • |drug |interactions: |induce |CYP 5-alpha |reductase |inhibitors |- |✔✔Finasteride |(Proscar)
  • |work |slowly |over |9-12 |months |to |reduce |size |of |prostate |gland
  • |MOA: |converts |testosterone |to |dihydrotestosterone |(DHT). |Decreasing |DHT |shrinks |prostate |gland | and |urine |outflows |improves | Dutasteride |(Avodart)
  • |more |expensive |than |finasteride
  • |must |be |used |in |combination |with |alpha |blocker
  • |can |prevent |hair |loss Finasteride |(Proscar) |- |✔✔5-alpha |reductase |inhibitors. |Finasteride |treats |BPH |by |blocking |the |body's | production |of |a |male |hormone |that |causes |the |prostate |to |enlarge.

ADE: |decreased |ejaculation, |decreased |libido, |erectile |dysfunction, |gynecomastia, |oligoslermia Teratogenic |for |women. |Can |cause |birth |defects |in |male |genitalia |of |fetus. |(Hypospadias) Over |active |detrusor |- |✔✔Most |common |in |geriatric. |They |go |on |their |way |to |the |bathroom. | Anticholinergics |or |smooth |muscle |relaxants |can |be |given. |

  • |propantheline -dicyclomine
  • |tofranil |or |doxepin
  • |ditropan Oxybutynin |(Ditropan) |- |✔✔Genitourinary |Medication, |Anticholinergic. |Used |for |overactive |bladder. | Side |effects: |dry |mouth, |blurry |vision, |constipation. Tolterodine |(Detrol) |- |✔✔overactive |bladder |with |symptoms |of |urge |urinary |incontinence, |urgency, | and |frequency. |Antimuscarinic. Trospium |(Sanctura) |- |✔✔Muscarinic |Receptor |Antagonist |-- |Overactive |Bladder. |Must |be |taken |on |an |empty |stomach. |ADE: |dry |mouth, |constipation, |blurred |vision Darifenacin |(Enablex) |- |✔✔Overactive |bladder: •common |side |effects |are |dry |mouth, |dry |eyes, |headache |and |constipation •check |heart |rate |at |least |once |daily |and |report |chest |pain |or |irregularities | •avoid |antihistamines | •avoid |dehydration |and |overheating | •avoid |alcohol •avoid |driving |until |side |effects |are |known | •rotate |sites |on |transdermal |patch Treatment |of |urinary |incontinence |- |✔✔The |management |of |Urinary |Incontinence |falls |into |four | broad |categories: |Behavioral |techniques, |devices |(catheters), |medications, |and |surgery.